← back to search

Marco Jost

Harvard University · US
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include CRISPR and Genetic Engineering, Porphyrin Metabolism and Disorders, Single-cell and spatial transcriptomics, and DNA Repair Mechanisms.
h-index
36
citations
6,493
works
105
NIH funding
primary concept
Biology
email

Recent publications

Comprehensive interrogation of synthetic lethality in the DNA damage response.
2025cited by 31position: contributordoi
A DNA-gated molecular guard controls bacterial Hailong anti-phage defence
Nature 2025cited by 12position: middledoi
A DNA-gated molecular guard controls bacterial Hailong anti-phage defence.
2025cited by 9position: contributordoi
Vaginal lactobacilli produce anti-inflammatory β-carboline compounds.
2024cited by 27position: contributordoi
Dissecting host-microbe interactions with modern functional genomics.
2024cited by 4position: contributordoi
Microfluidics-free single-cell genomics with templated emulsification
Nature Biotechnology 2023cited by 203position: middledoi
Microfluidics-free single-cell genomics with templated emulsification.
2023cited by 156position: contributordoi
Structural insight into G-protein chaperone-mediated maturation of a bacterial adenosylcobalamin-dependent mutase
Journal of Biological Chemistry 2023cited by 3position: middledoi
Structural insight into G-protein chaperone-mediated maturation of a bacterial adenosylcobalamin-dependent mutase.
2023cited by 2position: contributordoi
Comprehensive Interrogation of Synthetic Relationships in the Human DNA Damage Response
2023cited by 1position: contributordoi
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Cell 2022cited by 636position: middledoi
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq.
2022cited by 529position: contributordoi
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors
eLife 2022cited by 148position: lastdoi
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.
2022cited by 125position: contributordoi
Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice
Nature Biotechnology 2022cited by 38position: middledoi
Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice.
2022cited by 31position: contributordoi
Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication.
2022cited by 21position: contributordoi
High-content imaging-based pooled CRISPR screens in mammalian cells.
2021cited by 77position: contributordoi
Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells
eLife 2021cited by 43position: middledoi
Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells.
2021cited by 36position: contributordoi
CRISPR-based functional genomics in human dendritic cells
eLife 2021cited by 27position: firstdoi
CRISPR-based functional genomics in human dendritic cells.
2021cited by 21position: contributordoi
GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control
Molecular Cell 2020cited by 175position: middledoi
Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs
Nature Biotechnology 2020cited by 173position: firstdoi
Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs.
2020cited by 160position: contributordoi
GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control.
2020cited by 151position: contributordoi
Mismatch-CRISPRi Reveals the Co-varying Expression-Fitness Relationships of Essential Genes in Escherichia coli and Bacillus subtilis
Cell Systems 2020cited by 146position: middledoi
Mismatch-CRISPRi Reveals the Co-varying Expression-Fitness Relationships of Essential Genes in Escherichia coli and Bacillus subtilis.
2020cited by 126position: contributordoi
High-content imaging-based pooled CRISPR screens in mammalian cells
The Journal of Cell Biology 2020cited by 88position: middledoi
Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent
Molecular Cell 2020cited by 60position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathan S. Weissman · Howard Hughes Medical Institute33 papers (2016–2023) · 12 papers (2019–2025)Catherine L. Drennan · Howard Hughes Medical Institute11 papers (2012–2023) · 10 papers (2019–2023)Max A. Horlbeck · Boston Children's Hospital7 papers (2016–2021)Thomas M. Norman · South Dakota State University6 papers (2016–2022)Joseph M. Replogle · University of San Francisco5 papers (2019–2023)Luke A. Gilbert · City College of San Francisco5 papers (2016–2022)Martin Kampmann · University Memory and Aging Center4 papers (2017–2022)Martin Kampmann · University Memory and Aging Center4 papers (2020–2022)Max Horlbeck · Neurological Surgery4 papers (2019–2021)Christina R. Liem · University of California, San Francisco4 papers (2020–2022)Jeffrey A. Hussmann · Massachusetts Institute of Technology4 papers (2020–2022)Yuwen Chen · National Health Research Institutes3 papers (2016–2020) · 3 papers (2019–2023)Min Y. Cho · Howard Hughes Medical Institute3 papers (2016–2020)Marvin E. Tanenbaum · Royal Netherlands Academy of Arts and Sciences3 papers (2017–2020)S. Padmanabhan · Imperial College Healthcare NHS Trust3 papers (2015–2017)Fangyi Chen · Columbia University2 papers (2016–2019)Jacob J. Stern · Howard Hughes Medical Institute2 papers (2017–2020)